To: SSP who wrote (59512 ) 8/17/2000 5:45:40 PM From: StocksDATsoar Respond to of 150070 Applies to -- COX -- ESTG ELAST Technologies Announces Immediate Chiropractic Market Opportunity for Its ELAST Device ELAST Technologies Announces Immediate Chiropractic Market Opportunity for Its ELAST Device 6 LAS VEGAS, Aug 17, 2000 (BUSINESS WIRE) -- ELAST Technologies, Inc., (OTC-BB: ESTG) www.elast.com announced this afternoon that it will be working with the World Chiropractic Alliance to market the ELAST Device(TM) in its current stage of development to chiropractors. The World Chiropractic Alliance ("WCA"), founded in 1989, is a non-profit "watch-dog" and advocacy organization, which represents more than 60,000 chiropractors worldwide (approximately 50,000 in the US). The WCA has determined that, in its current stage of development, the ELAST Device(TM) can provide vital measurements to the chiropractic practitioner and WCA Founder and President Terry A. Rondberg, D.C., has agreed to assist ELAST Technologies in the marketing of the Device to the chiropractic community. 6 The ELAST Device(TM) is a patented, non-invasive diagnostic tool designed to accurately diagnose allergies, as well as food and chemical sensitivities immediately without any of the pain or expense associated with currently employed testing methods. The ELAST Device(TM) is being designed to test for allergies and sensitivities non-invasively through means of simple exposure and is based upon the clinical observation that the normal flow of electricity in the human body is altered when its immune system is exposed to a substance to which it is sensitive or allergic. 6 The non-invasive nature of the ELAST Device(TM) is possible because the device measures the body's electrical response when it is exposed to an allergen. It is this very measurement of the body's electrical responses that is of great use to the chiropractic community. Chiropractors have long sought objective means to measure and thereby validate their treatment protocols. The ELAST Device's ability to measure the body's electrical response is such an objective test. 6 Thomas F. Krucker, ELAST President and CEO, announced this marketing opportunity this afternoon during his address to the members of the Regional Investment Bankers Association (RIBA) during its Chicago Capital Conference at the Ritz Carlton Four Seasons Hotel. Mr. Krucker stated, that even with very conservative financial assumptions, the chiropractic market can provide a strong revenue stream for the Company in the near term. With the assistance of the WCA, ELAST Technologies is confident that the WCA's member chiropractors will be quite eager to use the ELAST Device(TM) in their practices, and by employing a leasing program coupled with a fee per test the cost would be minimal to the chiropractor. ELAST Technologies projects total revenues for the first year, based on 500 units leased, to approximate $4.5 million. 6 ELAST Technologies, Inc., is a research and development enterprise whose primary business is the development of the ELAST Device(TM). The U.S. allergy testing market is estimated to be a $6 billion annual market (and is estimated to be a $12 billion annual market worldwide). 6 This news release contains forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product development and consumer demand and acceptance, changes in technology, ability to raise capital, the availability of appropriate acquisition candidates and/or business partnerships, economic conditions, impact of competition and pricing, capacity and supply constraints or difficulties, government regulation and other risks. All such forward-looking statements whether written or oral, and whether made by or on behalf of the Company are expressly qualified by these cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof. CONTACT: ELAST Technologies, Inc., Las Vegas Michael Nanry, 877/ELASTEC (877/352-7832) URL: businesswire.com Today's News On The Net - Business Wire's full file on the Internet with Hyperlinks to your home page. Copyright (C) 2000 Business Wire. All rights reserved. -0- KEYWORD: NEVADA INDUSTRY KEYWORD: MEDICAL DEVICES MEDICAL PRODUCT